Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Cell Culture Center (NCCC) was a specialized resource center funded by the National Institutes of Health (NIH) to provide large-scale mammalian cell culture and protein purification services to the biomedical research community. Operated by the Hennepin Healthcare Research Institute (formerly Minneapolis Medical Research Foundation), the center focused on scaling up the production of monoclonal antibodies, recombinant proteins, and specialized cell lines for academic and government researchers. By providing access to industrial-scale bioreactors and bioprocessing expertise, the NCCC enabled scientists to obtain high-quality biological materials necessary for advanced preclinical studies that would otherwise be cost-prohibitive. The center served as a vital component of the U.S. research infrastructure for over two decades before its centralized funding was phased out in favor of commercial contract manufacturing alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Cell Culture Center.